Syndax Pharmaceuticals Inc Sustainability Reports
Syndax Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company focused on developing and commercializing an innovative pipeline of cancer therapies. Its pipeline includes targeted therapies like menin inhibitors and monoclonal antibodies for various malignancies.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 529900OF94TRHKZVBS87
FIGI: BBG001T92272
5 reports from 2017 to 2024